DocSym
β
Searchsearch
Search
(G63.5*) Polyneuropathy in systemic connective tissue disorders
More details coming soon
NaN% mortality rate associated with the disease polyneuropathy in systemic connective tissue disorders
Diagnosis polyneuropathy in systemic connective tissue disorders is diagnosed Prevalent in Women Only
0
Men receive the diagnosis polyneuropathy in systemic connective tissue disorders
0 (No mortality)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
0
Women receive the diagnosis polyneuropathy in systemic connective tissue disorders
0 (No mortality)Died from this diagnosis.
Risk Group for the Disease polyneuropathy in systemic connective tissue disorders - Men and Women aged 0
No Cases of the Disease Polyneuropathy in systemic connective tissue disorders identified in Men
Less common in men the disease occurs at Age 0-95+Less common in women the disease occurs at Age 0-95+
No Cases of the Disease Polyneuropathy in systemic connective tissue disorders identified in Men
Disease Features polyneuropathy in systemic connective tissue disorders
Absence or low individual and public risk
Polyneuropathy in systemic connective tissue disorders - what does this mean
Polyneuropathy in systemic connective tissue disorders is a neurological disorder which occurs when the peripheral nerves become damaged due to inflammation of the connective tissue in the body. this can lead to numbness, pain, and weakness in the affected areas. it is most commonly associated with autoimmune diseases such as rheumatoid arthritis and lupus.
What happens during the disease - polyneuropathy in systemic connective tissue disorders
Polyneuropathy in systemic connective tissue disorders is caused by a combination of factors, including inflammation, autoimmune attack, and metabolic derangements. it is characterized by progressive damage to peripheral nerves, resulting in muscle weakness, sensory deficits, and autonomic dysfunction. the exact pathogenesis of the condition is still unknown, but it is believed to involve a combination of genetic, environmental, and immunological factors.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete physical examination
- Laboratory tests such as complete blood count, erythrocyte sedimentation rate (ESR), antinuclear antibody (ANA) test, rheumatoid factor (RF), and thyroid-stimulating hormone (TSH) level
- Electromyography (EMG) and nerve conduction studies (NCS)
- Magnetic resonance imaging (MRI) of the spine
- X-rays of the spine and other affected joints
- Blood tests to measure levels of immunoglobulin
- Skin biopsy
- Lumbar puncture
Treatment and Medical Assistance
Main goal of the treatment: To reduce pain and improve functioning in people with polyneuropathy in systemic connective tissue disorders.
- Treating underlying medical conditions that may be causing polyneuropathy
- Managing pain with medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, and opioids
- Physical therapy to reduce pain and improve muscle strength and flexibility
- Occupational therapy to help with activities of daily living
- Counseling to help with managing stress and depression
- Assistive devices to help with mobility
- Surgery to correct any underlying issues causing the polyneuropathy
No Hospitalization Required
Average Time for Outpatient Care Not Established
Polyneuropathy in systemic connective tissue disorders - Prevention
Polyneuropathy in systemic connective tissue disorders can be prevented by maintaining a healthy lifestyle, which includes regular exercise, eating a balanced diet, and avoiding smoking and excessive alcohol consumption. additionally, it is important to take any prescribed medications as directed by a doctor and to monitor any changes in health that could indicate the onset of a systemic connective tissue disorder.